Longitudinal assessment of anti-Mullerian hormone after cesarean section and influence of bilateral salpingectomy on ovarian reserve

被引:8
作者
Ida, Tsutomu [1 ]
Fujiwara, Hiroyuki [2 ]
Taniguchi, Yoshimi [1 ]
Kohyama, Akira [1 ]
机构
[1] Tokyo Metropolitan Tama Med Ctr, Dept Obstet & Gynecol, Fuchu, Tokyo, Japan
[2] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan
关键词
Anti-Mullerian hormone; Cesarean section; Ovarian function; Salpingectomy; Tubal ligation; Permanent contraception; SERUM ANTIMULLERIAN HORMONE; TUBAL-LIGATION; INHIBIN-B; WOMEN; STERILIZATION; AGE; HYSTERECTOMY; PREGNANCY; CANCER;
D O I
10.1016/j.contraception.2021.01.016
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study aimed to compare longitudinal changes in ovarian reserve markers after cesarean section (CS) with and without bilateral salpingectomy (BS). Study design: We prospectively enrolled women >35 weeks' gestation scheduled for CS alone or CS + BS and obtained blood samples for anti-Mullerian hormone prior to surgery and at 3 and 6 months after surgery. At the 3-month visit, we similarly performed transvaginal ultrasound for antral follicle count. Results: We enrolled 50 women; 30 underwent CS only and 20 underwent CS + BS. Although anti-Mullerian hormone level increased over 6 months of follow-up in both groups, no clinically important differences in the geometric mean (interquartile range) (ng/mL) were observed at any timepoint (baseline [0.69 {0.36-1.21} {CS only} vs 0.49 {0.32-2.10} {CS + BS}, p = 0.64]; 3 months [1.35 {0.58-3.13} vs 1.45 {1.04-2.25}, p = 0.79]; and 6 months [1.74 {0.93-4.45} vs 2.60 {1.41-5.10}, p =0.27]). Similarly, we detected no difference in antral follicle count. Conclusion: BS at the time of CS does not have a negative impact on ovarian reserve 6 months after surgery. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:394 / 399
页数:6
相关论文
共 50 条
[41]   Anti-Mullerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review [J].
Anderson, Richard A. ;
Cameron, David ;
Clatot, Florian ;
Demeestere, Isabelle ;
Lambertini, Matteo ;
Nelson, Scott M. ;
Peccatori, Fedro .
HUMAN REPRODUCTION UPDATE, 2022, 28 (03) :417-434
[42]   Can delivery mode influence future ovarian reserve? Anti-Mullerian hormone levels and antral follicle count following cesarean section: a prospective cohort study [J].
Ashraf Moini ;
Reihaneh Pirjani ;
Maryam Rabiei ;
Maryam Nurzadeh ;
Mahdi Sepidarkish ;
Reihaneh Hosseini ;
Ladan Hosseini .
Journal of Ovarian Research, 12
[43]   Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve [J].
van Rooij, IAJ ;
Broekmans, FJM ;
te Velde, ER ;
Fauser, BCJM ;
Bancsi, LFJMM ;
de Jong, FH ;
Themmen, APN .
HUMAN REPRODUCTION, 2002, 17 (12) :3065-3071
[44]   Anti-Mullerian hormone and ovarian aging in mares [J].
Uliani, Renata C. ;
Conley, Alan J. ;
Corbin, C. Jo ;
Friso, Aime M. ;
Maciel, Luciana F. S. ;
Alvarenga, Marco A. .
JOURNAL OF ENDOCRINOLOGY, 2019, 240 (02) :147-156
[45]   Anti-Mullerian hormone reduction after ovarian cyst surgery is dependent on the histological cyst type and preoperative anti-Mullerian hormone levels [J].
Lind, Tekla ;
Hammarstrom, Margareta ;
Lampic, Claudia ;
Rodriguez-Wallberg, Kenny .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2015, 94 (02) :183-190
[46]   Anti-Mullerian hormone as a marker of ovarian reserve in patients with ovarian malignancies who have undergone fertility-preserving surgery and chemotherapy [J].
Iwase, Akira ;
Sugita, Atsuko ;
Hirokawa, Wakana ;
Goto, Maki ;
Nakahara, Tatsuo ;
Bayasula ;
Kajiyama, Hiroaki ;
Shibata, Kiyosumi ;
Nagatomo, Yoshinari ;
Kikkawa, Fumitaka .
GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (04) :357-360
[47]   Effect of anti-mullerian hormone, FSH and LH in evaluating ovarian reserve after laparoscopy surgery [J].
Zhao, Fen ;
Zhu, Jing ;
Pan, Shanshan ;
Yang, Jianhua .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02) :2313-2318
[48]   Assessment of ovarian reserve by serum anti-Mullerian hormone in patients with systemic lupus erythematosus: a meta-analysis [J].
Luo, Wanwan ;
Mao, Panying ;
Zhang, Lingmin ;
Chen, Xiaoyu ;
Yang, Zaixing .
ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (02) :207-215
[49]   The ovarian reserve as measured by the anti-Mullerian hormone is not diminished in patients with rheumatoid arthritis compared to the healthy population [J].
Lopez-Corbeto, M. ;
Martinez-Mateu, S. ;
Pluma, A. ;
Ferrer, R. ;
Lopez-Lasanta, M. ;
De Agustin, J. J. ;
Barcelo, M. ;
Julia, A. ;
Marsal, S. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (02) :337-343
[50]   Anti-Mullerian Hormone as a marker of ovarian reserve in relation to cardio-metabolic health: A narrative review [J].
de Kat, Annelien C. ;
Broekmans, Frank J. M. ;
Laven, Joop S. ;
van der Schouw, Yvonne T. .
MATURITAS, 2015, 80 (03) :251-257